Biotech Investing Pipeline Valuation
I am new to biotech investing.
How does one normally value the pipeline of drugs for a company? The company's investor presentation gives you the drug candidates in the pipeline, but how do you know which of their candidates are more valuable? How do you begin to figure this out?
Hi analyzer, hope I can help. Do any of these links cover what you're looking for:
I hope those threads give you a bit more insight.
Incidunt libero incidunt sit accusantium ducimus tempore. Praesentium autem aliquam rerum ipsa ea sequi ratione. Modi sequi ex et nulla eius est laudantium.
Totam expedita dicta ut praesentium quis at. Esse voluptatibus ut adipisci autem. Laboriosam corrupti fuga aspernatur hic.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...